| scholarly article | Q13442814 |
| P2093 | author name string | Meng Chen | |
| Pengfei Wu | |||
| Qun Chen | |||
| Jinquan Cai | |||
| Chuanlu Jiang | |||
| Jiawei Dong | |||
| Yuqiong Cui | |||
| P2860 | cites work | Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles | Q24536351 |
| ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks | Q24570122 | ||
| Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer | Q24633070 | ||
| Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 | Q24651548 | ||
| Neoplastic "Black Ops": cancer's subversive tactics in overcoming host defenses | Q27001081 | ||
| Structural and functional features of central nervous system lymphatic vessels | Q27316769 | ||
| Cancer-related inflammation | Q27860907 | ||
| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma | Q27860910 | ||
| Prospects of immune checkpoint modulators in the treatment of glioblastoma | Q28081371 | ||
| The somatic genomic landscape of glioblastoma | Q28300185 | ||
| Macrophage diversity enhances tumor progression and metastasis | Q29615847 | ||
| Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells | Q33779042 | ||
| IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways | Q33888307 | ||
| Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties. | Q34132823 | ||
| IL-10 elicits IFNγ-dependent tumor immune surveillance. | Q34240935 | ||
| Depletion of carcinoma-associated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival | Q34269713 | ||
| Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity | Q34287535 | ||
| Insulin-like growth factors and neoplasia. | Q34330521 | ||
| Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions | Q34477550 | ||
| Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis | Q35085674 | ||
| circlize Implements and enhances circular visualization in R. | Q35188401 | ||
| Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells | Q35329234 | ||
| Identification of a 6-cytokine prognostic signature in patients with primary glioblastoma harboring M2 microglia/macrophage phenotype relevance | Q35610772 | ||
| Insulin-like growth factor-binding protein 2-driven glioma progression is prevented by blocking a clinically significant integrin, integrin-linked kinase, and NF-κB network | Q35807732 | ||
| Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors | Q35811255 | ||
| Increased immune gene expression and immune cell infiltration in high-grade astrocytoma distinguish long-term from short-term survivors. | Q36139736 | ||
| Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma. | Q36248008 | ||
| Prognostically relevant gene signatures of high-grade serous ovarian carcinoma | Q36497294 | ||
| Galectin-1 drives lymphoma CD20 immunotherapy resistance: validation of a preclinical system to identify resistance mechanisms | Q36800456 | ||
| Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer | Q36853817 | ||
| Inhibition of Soluble Tumor Necrosis Factor Prevents Chemically Induced Carcinogenesis in Mice | Q36917707 | ||
| The role of microglia and macrophages in glioma maintenance and progression | Q36924298 | ||
| Insulin-like growth factor-binding protein-2 is a target for the immunomodulation of breast cancer | Q37001399 | ||
| Glioma progression is mediated by an addiction to aberrant IGFBP2 expression and can be blocked using anti-IGFBP2 strategies | Q37026424 | ||
| IGFBP2 is a candidate biomarker for Ink4a-Arf status and a therapeutic target for high-grade gliomas | Q37377386 | ||
| Epigenetic regulation of the alternatively activated macrophage phenotype | Q37381695 | ||
| Interaction between ANXA1 and GATA-3 in Immunosuppression of CD4+ T Cells | Q37385867 | ||
| Immune heterogeneity of glioblastoma subtypes: extrapolation from the cancer genome atlas | Q37435455 | ||
| Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma | Q37477267 | ||
| Tumor-recruited M2 macrophages promote gastric and breast cancer metastasis via M2 macrophage-secreted CHI3L1 protein | Q37618668 | ||
| Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment | Q37970682 | ||
| Mechanisms of immune evasion by gliomas | Q38013708 | ||
| Glioblastoma survival: has it improved? Evidence from population-based studies. | Q38264492 | ||
| Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade. | Q38707904 | ||
| Signal Peptide Peptidase, Encoded by HM13, Contributes to Tumor Progression by Affecting EGFRvIII Secretion Profiles in Glioblastoma | Q38960961 | ||
| Tissue inhibitor of metalloproteinases (TIMP)-1 creates a premetastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice | Q38965104 | ||
| A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice | Q39666028 | ||
| Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade | Q40082476 | ||
| Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples | Q42777737 | ||
| VEGFA/VEGFR2-targeted therapies prevent the VEGFA-induced proliferation of regulatory T cells in cancer | Q42969280 | ||
| CD29 and CD7 mediate galectin-3-induced type II T-cell apoptosis | Q44695762 | ||
| Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege | Q47860342 | ||
| Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen-induced arthritis. | Q47948464 | ||
| Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer | Q48002896 | ||
| Induction of Regulatory T Cells and Its Regulation with Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-4 by Human Mesenchymal Stem Cells | Q48099631 | ||
| CGCG clinical practice guidelines for the management of adult diffuse gliomas | Q48843889 | ||
| CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013. | Q52096226 | ||
| Elevated serum antibodies against insulin-like growth factor-binding protein-2 allow detecting early-stage cancers: evidences from glioma and colorectal carcinoma studies | Q55462258 | ||
| P4510 | describes a project that uses | Cytoscape | Q3699942 |
| P433 | issue | 5 | |
| P304 | page(s) | e1426516 | |
| P577 | publication date | 2018-02-13 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples. | |
| P478 | volume | 7 |
| Q93060759 | An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma |
| Q92861639 | CD48 is a key molecule of immunomodulation affecting prognosis in glioma |
| Q91808981 | Expanding the scope of candidate prognostic marker IGFBP2 in glioblastoma |
| Q64067909 | Expression Profile Analysis Identifies a Novel Five-Gene Signature to Improve Prognosis Prediction of Glioblastoma |
| Q104130647 | Hub gene identification and prognostic model construction for isocitrate dehydrogenase mutation in glioma |
| Q90012407 | IGFBP5 increases cell invasion and inhibits cell proliferation by EMT and Akt signaling pathway in Glioblastoma multiforme cells |
| Q57116103 | Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-β pathway |
| Q92355905 | Overexpression of IGFBP2 mRNA predicts poor survival in patients with glioblastoma |
| Q89763243 | Tracking intratumoral heterogeneity in glioblastoma via regularized classification of single-cell RNA-Seq data |
Search more.